KIF2C and cervical squamous cell carcinoma: The CESC patients with KIF2C genetic alteration had poor prognosis in OS (Figure 4C, p = 0.047), progression-free survival (Figure 4C, p < 0.001), DFS (Figure 4C, p < 0.001), and DSS (Figure 4C, p = 0.0167).